University of Maryland School of Medicine logo
Maryland Addiction Consultation Service (MACS)
All Departments
UMSOM Assistant
MACS Materials & Fact Sheets
  • Home
  • MACS
  • Resources
  • MACS Materials & Fact Sheets
  • Resources
  • Overview
  • MOUD Overview
  • Stigma in Healthcare Settings
  • MACS Materials & Fact Sheets
  • Practice Guidance & Clinical Resources
  • MACS Monthly Newsletter

Provider Fact Sheets

Buprenorphine and Pain

Starting Buprenorphine: Tips for Filling Your Prescription

Accessible Format: Starting Buprenorphine: Tips for Filling Your Prescription

High-Dose Buprenorphine: Clinical Considerations

Accessible Format: High-Dose Buprenorphine: Clinical Considerations

Buprenorphine and Pain

Accessible Format: Buprenorphine and Pain

Kratom (Mitragynine)

Kratom (Mitragynine): Clinical Considerations

Accessible Format: Kratom (Mitragynine): Clinical Considerations

Medetomidine

Medetomidine in the Illicit Drug Supply: Emerging Clinical Challenges

Accessible Format: Medetomidine in the Illicit Drug Supply

Methadone

Methadone "3-Day" Dispensing Rule.pdf

Accessible Format: Methadone "3-Day" Dispensing Rule

Nalmefene

Naloxone vs. Nalmefene: Understanding the Evidence

Accessible Format: Naloxone vs. Nalmefene: Understanding the Evidence

Sleep and Opioid Use Disorder

The Role of Sleep and Suvorexant in Opioid Use Disorder Treatment

Accessible Format: The Role of Sleep and Suvorexant in OUD Treatment

Synthetic Cannabinoids

Synthetic Cannabinoids

Accessible Format Synthetic Cannabinoids

Tele-Medication for Opioid Use Disorder

Tele-MOUD Implementation Guide

Accessible Format Tele-MOUD Implementation Guide

Tianeptine and Phenibut

Tianeptine and Phenibut

Accessible Format: Tianeptine and Phenibut

Transitioning From Methadone to Buprenorphine

Transitioning From Methadone to Buprenorphine: General Guidance for Clinicians

Accessible Format: Transitioning From Methadone to Buprenorphine

Withdrawal

Opioid Withdrawal: The Importance of Self-Reported Symptoms

Accessible Format: Opioid Withdrawal: The Importance of Self-Reported Symptoms

Precipitated Withdrawl and Buprenorphine Induction

Accessible Format: Precipitated Withdrawal and Buprenorphine Induction

Xylazine

Xylazine and Opioid Use

Accessible Format: Xylazine and Opioid Use

Youth

Adolescents and Substance Use

Accessible Format: Adolescents and Substance Use

Medications for Opioid Use Disorder (MOUD) in Youth

Accessible Format: Medications for Opioid Use Disorder (MOUD) in Youth

Steps to Decrease the Impact of Parental or Household Substance Use on Youth

Accessible Format: Steps to Decrease the Impact of Parental Substance Use


Archived Additional Materials

The MACS team understands a number of the archived content items might not be accessible. Please contact us at 1-855-337-MACS (6227) or macs@som.umaryland.edu if support is needed to access the materials.

Buprenorphine Quick Start Guide

Accessible Format: Buprenorphine Quick Start Guide

Clinical Opiate Withdrawal Scale (COWS)

Controlled Substances Agreement

Accessible Format: Controlled Substances Agreement

Ways Healthcare Providers Can Prevent Overdose

Accessible Format: Ways Healthcare Providers Can Prevent Overdose


University of Maryland School of Medicine logo
  • Departments
  • Programs
  • Research Centers
  • Institutes
  • Graduate Education
  • CIBR Cores
  • Offices of the Dean
    • University of Maryland, Baltimore
    • University of Maryland Medical Center
    • Medical Alumni Association of the University of Maryland
    • Health Sciences and Human Services Library
University of Maryland School of Medicine
655 W. Baltimore Street
Baltimore, MD 21201
Contact Us

© University of Maryland School of Medicine

    • Webmaster
    • Web Accessibility
    • Site Index
    • UMB Hotline
    • Employment
    • Map